Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

31,229 signal articles · 30 in last 24h · 160,153 total before filter · latest 17h ago
30last 24h
725last 7d
101● bullish (7d)
75● bearish (7d)
214publishers
AllMacro147Earnings186M&A79Regulatory15Product12Analyst19
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Procter & Gamble (PG) Agrees To Buy Thorne For $3.8 Billion
Simply Wall St.58d agobullish
Procter & Gamble (PG) Agrees To Buy Thorne For $3.8 Billion

Procter & Gamble (NYSE:PG) agreed to acquire Thorne, a science-focused wellness supplements company. The transaction values Thorne at US$3.8b and expands PG into premium health and wellness categories. The deal centers on vitamins, minerals, and supplements as an extension of PG's existing health portfolio. For investors tracking Procter & Gamble, this move pushes the company further into consumer health and wellness rather than relying only on traditional household and personal care...

How Compass Earnings Blew Past Estimates in a Lousy Housing Market
Barrons.com58d agobullish
How Compass Earnings Blew Past Estimates in a Lousy Housing Market

Compass stock was rising in after-hours trading after the company reported earnings and issued guidance that exceeded consensus estimates. Compass’s ongoing integration of the Anywhere brokerage business and partnership with Redfin helped. Compass reported basic earnings of twelve cents a share, or eleven cents a share diluted, on $4.3 billion in revenue in its second quarter, the real estate brokerage said in a Tuesday announcement.

Booking (NASDAQ:BKNG) Beats Q2 CY2026 Sales Expectations
StockStory58d agobullish
Booking (NASDAQ:BKNG) Beats Q2 CY2026 Sales Expectations

Online travel agency Booking Holdings (NASDAQ:BKNG) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 8.1% year on year to $7.35 billion. Its non-GAAP profit of $2.54 per share was 4.5% above analysts’ consensus estimates.

Upstart (NASDAQ:UPST) Exceeds Q2 CY2026 Expectations, Stock Jumps 11.3%
StockStory58d agobullish
Upstart (NASDAQ:UPST) Exceeds Q2 CY2026 Expectations, Stock Jumps 11.3%

AI lending platform Upstart (NASDAQ:UPST) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 41.7% year on year to $364.7 million. On the other hand, the company’s full-year revenue guidance of $1.4 billion at the midpoint came in 1.7% below analysts’ estimates. Its GAAP profit of $0.16 per share was 16.7% below analysts’ consensus estimates.

Coinbase (COIN) Keeps Circle Partnership Terms Unchanged As USDC Renewal Kicks In
Simply Wall St.58d agobullish
Coinbase (COIN) Keeps Circle Partnership Terms Unchanged As USDC Renewal Kicks In

Coinbase Global and Circle confirmed that their commercial partnership will renew automatically on the same terms. The update ends speculation that the USDC agreement might be renegotiated following Coinbase's entry into the Open USD consortium. The renewal maintains existing economics around USDC for Coinbase without announced changes to revenue sharing. Coinbase Global, ticker NasdaqGS:COIN, is trading at $146.5, with the stock down 12.7% over the past week and 11.5% over the past month...

SpaceX revenue jumps 92% in first earnings report
AFP58d agobullish
SpaceX revenue jumps 92% in first earnings report

SpaceX's revenue jumped 92 percent in the second quarter, beating analyst expectations by around $1 billion in its first earnings report since going public in June, the company announced Tuesday.Investors remain skeptical even with SpaceX beating expectations, Emarketer Senior Analyst Gadjo Sevilla told AFP.  "I don't think people want to hear promises about the next five years or a mission to Mars," Sevilla said. 

Gilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026
StockStory58d agobullish
Gilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.2% year on year to $7.80 billion. On the other hand, the company’s full-year revenue guidance of $30.25 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP loss of $6.75 per share was 6.9% above analysts’ consensus estimates.

Arista Networks Stock Surges as Earnings Prove AI Demand Is Real
Barrons.com58d agobullish
Arista Networks Stock Surges as Earnings Prove AI Demand Is Real

Arista Networks stock soared Tuesday after the network infrastructure company reported better-than-expected second-quarter earnings. The results provided further evidence that demand for artificial-intelligence services is accelerating, with hardware suppliers like Arista among the main beneficiaries. Arista reported adjusted earnings of $1.02 a share for the second quarter, up from 73 cents last year and above analysts’ call for 89 cents, per FactSet.

Pinterest Earnings And Revenue Beat But Stock Slides Late
Investor's Business Daily58d agobullish
Pinterest Earnings And Revenue Beat But Stock Slides Late

Pinterest stock fell late Tuesday, despite reporting second-quarter results that topped expectations. Pinterest's in-line third-quarter guidance may have been a disappointment after rival digital ad platforms Reddit and Snap offered stronger forecasts. The San Francisco-based Pinterest earned an adjusted 43 cents per share for the June-ended quarter, up 30% from a year earlier and ahead of the 36 cents per share that analysts polled by FactSet were forecasting.